Curcumin-enhanced elvitegravir therapy mitigates neuroinflammation and cognitive deficits in EcoHIV mice
Experimental Biology and Medicine · 2025
DOI: 10.3389/ebm.2025.10758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2025. Verfasst von Sandip Godse und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States. Hauptthemen laut MEDLINE: Curcumin, Quinolones, Cognitive Dysfunction, Neuroinflammatory Diseases. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
HIV-associated neurocognitive disorders (HAND) persist in up to 50% of people living with HIV (PLWH) despite effective antiretroviral therapy (ART), driven by chronic neuroinflammation, oxidative stress, and neuronal damage. This study investigates the therapeutic potential of combining elvitegravir (EVG), an integrase strand transfer inhibitor, with curcumin (CUR), a natural polyphenol with anti-inflammatory and antioxidant properties, in a murine EcoHIV model of HAND. EcoHIV-infected mice were treated with EVG, CUR, or their combination (EVG + CUR), and cognitive, motor, and molecular outcomes were evaluated. Behavioral assays revealed that EcoHIV infection significantly impaired non-spatial working memory, spatial learning, and motor performance, as assessed by the Novel Object Recognition (NOR)and Morris water Maize (MWM) tests and CatWalk gait analysis. While EVG or CUR alone showed modest improvements, the EVG + CUR combination significantly restored cognitive function, reduced escape latencies in the MWM, and improved motor performance, including gait stability and interlimb coordination. At the molecular level, EVG + CUR treatment attenuated neuroinflammation by reducing pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and chemokine (MCP-1) in the brain and plasma, particularly following intranasal administration. Additionally, EVG + CUR significantly reduced oxidative DNA damage and preserved neuronal integrity without disrupting CNS homeostasis. These findings demonstrate that the EVG + CUR combination effectively targets both viral persistence and the underlying neuroinflammatory and oxidative mechanisms driving HAND. By improving cognitive and motor function while mitigating neuroinflammation and oxidative stress, EVG + CUR represents a promising adjunctive therapy for HAND, offering a multifaceted approach to addressing the complex pathophysiology of HIV-associated neurocognitive disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States.
- Department of Anatomy and Neurobiology, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, United States.
Förderung
- NIA NIH HHS
- NIMH NIH HHS
- National Institute of Mental Health
- National Institute on Aging
Zitieren
APA
Godse, S., Zhou, L., Sinha, N., Salman, M., Ishrat, T., & Kumar, S. (2025). Curcumin-enhanced elvitegravir therapy mitigates neuroinflammation and cognitive deficits in EcoHIV mice. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2025.10758
Vancouver
Godse S, Zhou L, Sinha N, Salman M, Ishrat T, Kumar S. Curcumin-enhanced elvitegravir therapy mitigates neuroinflammation and cognitive deficits in EcoHIV mice. Experimental Biology and Medicine. 2025. doi:10.3389/ebm.2025.10758
BibTeX
@article{Godse2025,
author = {Godse, Sandip and Zhou, Lina and Sinha, Namita and Salman, Mohd and Ishrat, Tauheed and Kumar, Santosh},
title = {Curcumin-enhanced elvitegravir therapy mitigates neuroinflammation and cognitive deficits in EcoHIV mice},
journal = {Experimental Biology and Medicine},
year = {2025},
doi = {10.3389/ebm.2025.10758}
}
EUVIMED